Jop Kind is a PI of the Blastoid consortium and a group leader at the Hubrecht Institute (since 2018) and Oncode Institute (since 2018). His groups aim is to obtain better understanding of the role of chromatin and epigenetics in gene regulation. More specifically, the work is directed towards understanding the mechanisms that govern the acquisition of new identities and traits in lineage specification events in early mouse development and in cancer. To this end his group employs and develops single-cell genomics technologies to delineate these processes in great detail and with high temporal resolution.
